[Polysomnographic results of surgical treatment of obstructive apnea syndrome].

PubWeight™: 0.75‹?›

🔗 View Article (PMID 13677020)

Published in Vestn Otorinolaringol on January 01, 2003

Authors

T P Sheludchenko, A S Lopatin, A L Kalinkin, A M Barkova

Articles by these authors

[Conductive hearing loss caused by eustachian tube dysfunction according to the data of functional computed tomography]. Vestn Rentgenol Radiol (2012) 0.78

[Early Stages of Parkinson's Disease: Comparative Characteristics of Sleep-Wakefulness Cycle in Patients and Model Animals]. Fiziol Cheloveka (2016) 0.77

Marinobufagenin in hypertensive patients with obstructive sleep apnea. Cell Mol Biol (Noisy-le-grand) (2006) 0.76

[Peculiarities of the surgical treatment of nasal septum perforations]. Vestn Otorinolaringol (2012) 0.76

[Hemorrhage following tonsillectomy: analysis of the prevalence and risk factors]. Vestn Otorinolaringol (2013) 0.76

[Diagnosis of anaphylactic shock caused by antibiotics]. Antibiotiki (1977) 0.75

[The effectiveness of long-term treatment of polypous rhinosinusitis with low doses of macrolides]. Vestn Otorinolaringol (2013) 0.75

[The anti-inflammatory properties of fusafungine]. Vestn Otorinolaringol (2010) 0.75

[Endonasal endoscopic orbital decompression through the transethmoidal approach]. Vestn Otorinolaringol (2009) 0.75

[Efficacy of the drug IRS 19 in prophylaxis of complications in rhinosurgical interventions]. Vestn Otorinolaringol (2006) 0.75

[A new variant of choanal polyps]. Vestn Otorinolaringol (2001) 0.75

[The state of the stirrup prosthesis estimated from the results of functional multispiral computed tomography]. Vestn Otorinolaringol (2012) 0.75

[Experience with the use of magnetic nanoparticles in medicine and prospects for their application in otorhinolaringology]. Vestn Otorinolaringol (2009) 0.75

[Control and study of drug side effects in therapeutic institutions]. Sov Med (1980) 0.75

[Theoretical calculation of the spatial distribution of a Co 60 gamma radiation dose field under a grid]. Med Radiol (Mosk) (1971) 0.75

[Efficiency of intraoral applicator UPLH-01 in snore and obstructive sleep apnea]. Klin Med (Mosk) (2001) 0.75

[Nasonex effectiveness in allergic rhinitis and chronic polypous rhinosinusitis]. Vestn Otorinolaringol (2000) 0.75

[The nasal valve. Part II. The modern methods for the conservative and surgical treatment of its pathology]. Vestn Otorinolaringol (2012) 0.75

[Maxillary puncture: endoscopic assessment]. Vestn Otorinolaringol (2006) 0.75

[A device for careful probing of the frontal sinus]. Vestn Otorinolaringol (1987) 0.75

[The incidence of detecting paranasal sinus pathology based on magnetic resonance and computed tomographic data]. Vestn Otorinolaringol (1997) 0.75

[The Hummer Microdebrider--new technology in functional endonasal rhinosurgery]. Vestn Otorinolaringol (1997) 0.75

[Functional multispiral computed tomography of sound-transmitting structures in the middle ear]. Vestn Otorinolaringol (2011) 0.75

[The nasal valve. Part I. Anatomical and physiological nature, clinical manifestations of dysfunction and methods for its diagnostics]. Vestn Otorinolaringol (2012) 0.75

[Giant laryngopharyngeal angiofibroma and an organ-sparing method for its removal]. Vestn Otorinolaringol (1986) 0.75

[Potentials for the endonasal endoscopic surgery in the treatment of maxillary cysts]. Vestn Otorinolaringol (2000) 0.75

[The problem of drug side effects]. Ter Arkh (1992) 0.75

Consensus Conference on Nasal Polyposis. Acta Otorhinolaryngol Ital (2004) 0.75

[The assessment of the state of the immune system in the patients presenting with bronchial asthma and concomitant diseases of the nasal cavity and paranasal sinuses]. Vestn Otorinolaringol (2012) 0.75

[Characteristics of drug-induced anaphylactic shock]. Sov Med (1985) 0.75

[The potential of multislice computed tomography for the detection of specific anatomic and topographic features of the facial nerve canal prior to stapedoplasty]. Vestn Otorinolaringol (2012) 0.75

[The use of functional multispiral computed tomography for differential diagnostics of otosclerosis and congenital malformation of the internal and middle ear (a case report)]. Vestn Otorinolaringol (2012) 0.75

[Oropharyngeal candidiasis in the practical work of the otorhinolaryngologist]. Vestn Otorinolaringol (2010) 0.75

[Dosage calculation based on x-ray tonometric data in the intracavitary irradiation of cervical cancer patients]. Med Radiol (Mosk) (1981) 0.75

[Endoscopic rhinosurgery: from simple intranasal surgery to interventions on orbital apex and base of the skull]. Vestn Otorinolaringol (2009) 0.75

[Efficacy of perioperative prophylaxis with bioparox in surgical interventions on the nasal cavity and paranasal sinuses]. Vestn Otorinolaringol (2006) 0.75

[Application of sinuforte in domestic and foreign practices]. Vestn Otorinolaringol (2010) 0.75

[Method for calculating the dose field of Co60 gamma radiation in external irradiation through a grid]. Radiobiol Radiother (Berl) (1973) 0.75

[Tonsillectomy in children: how it is performed in Europe and America?]. Vestn Otorinolaringol (2013) 0.75

[Levocetirizine in therapy for allergic rhinitis]. Vestn Otorinolaringol (2010) 0.75

[The estimation of the efficacy of manual therapy included in the combined treatment of cochlear-vestibular disorders based on the results of computed stabilography]. Vestn Otorinolaringol (2012) 0.75

[Cardiac arrest in a patient with obstructive sleep apnea during sleep]. Ter Arkh (2004) 0.75

[Organ-sparing treatment of polypous sinusitis]. Vestn Otorinolaringol (1987) 0.75

[Application of the navigation system in endoscopic surgery of paranasal sinuses and base of the skull]. Vestn Otorinolaringol (2005) 0.75

[Olfactory disorders and their correction]. Vestn Otorinolaringol (2007) 0.75

[Secondary operations for the treatment of nasal septum deformities]. Vestn Otorinolaringol (2013) 0.75

[Calculation of the depth dose of radiation with Co60 during distant irradiation thru a grid]. Med Radiol (Mosk) (1971) 0.75

[The use of screening methods in diagnosis of disturbances of respiration during sleep in patients with cardiac pathology]. Kardiologiia (2011) 0.75

[Abdominal variant of drug-induced anaphylactic shock]. Ter Arkh (1981) 0.75

[Efficiency of sinuforte in combined therapy of acute suppurative rhinosinusitis]. Vestn Otorinolaringol (2009) 0.75

[The influence of the surgical and medicamental treatment on the olfactory function in the patients presenting with polypous rhinosinusitis]. Vestn Otorinolaringol (2012) 0.75

[Spontaneous nasal liquorrhea and the Sternberg canal: scientific hypothesis and personal experience]. Vestn Otorinolaringol (2014) 0.75

[The role of the topical corticosteroid therapy in the treatment of chronic polypous rhinosinusitis]. Vestn Otorinolaringol (1999) 0.75

[Endoscopic diagnosis and treatment of nasal rhinorrhea]. Vestn Otorinolaringol (2003) 0.75

[Main principles of functional intranasal surgery of paranasal sinuses]. Vestn Otorinolaringol (1996) 0.75

[Ebastine (kestine 20) in therapy of allergic rhinitis]. Vestn Otorinolaringol (2007) 0.75

[Anti-inflammatory therapy of paranasal sinuses diseases]. Vestn Otorinolaringol (2006) 0.75

[The results of the surgical treatment of otosclerosis in the elderly subjects]. Vestn Otorinolaringol (2014) 0.75

[The diagnostic efficiency of the methods of separate and combined registration of oronasal airflow and pulse oximetry for detection of the obstructive sleep apnea/hypopnea syndrome]. Kardiologiia (2013) 0.75

[Therapy of imudon after tonsillectomy]. Vestn Otorinolaringol (2006) 0.75

[Drugs do not cause diseases]. Sov Med (1984) 0.75

[Clinical and statistical analysis of the side effects and complications of antibiotic therapy]. Antibiotiki (1977) 0.75

[Combined treatment of productive forms of chronic polysinusitis]. Vestn Otorinolaringol (1986) 0.75

[Chronic rhinosinusitis: epidemiology, classification, etiology, and pathogenesis. The current view of the problem]. Vestn Otorinolaringol (2012) 0.75

[Treatment of status epilepticus with the intravenous administration of aminazine]. Zh Nevropatol Psikhiatr Im S S Korsakova (1968) 0.75

[Peculiarities of sanitizing middle ear reoperations]. Vestn Otorinolaringol (2009) 0.75

[Gamma-therapy by irradiation through a membrane in patients with neglected forms of malignant tumors]. Med Radiol (Mosk) (1973) 0.75

[Collimator for measuring coronary circulation with the aid of precordial counting]. Med Tekh (1977) 0.75

[Pattern of ENT problems in patients with primary defects of humoral immunity]. Vestn Otorinolaringol (2002) 0.75

[Endoscopic endonasal diagnosis and treatment of basal liquorrhea and encephalocele of the anterior regions of the skull base]. Zh Vopr Neirokhir Im N N Burdenko (2002) 0.75

Determination of the parameters of gratings used in x-ray and gamma therapy. Biomed Eng (NY) (1972) 0.75

[The influence of different methods of surgical intervention on mucosal microcirculation in the inferior turbinate bone evaluated by laser Doppler flowmetry]. Vestn Otorinolaringol (2009) 0.75

[Our experience with the application of collagen-based preparations in reconstructive surgery of the middle ear]. Vestn Otorinolaringol (2012) 0.75

[Avelox efficacy in the treatment of acute purulent rhinosinusitis]. Ter Arkh (2007) 0.75

[The evolution of adenoidectomy]. Vestn Otorinolaringol (2013) 0.75

[Endoscopic surgical treatment of vascular tumors of the paranasal sinuses and base of the skull]. Vestn Otorinolaringol (2008) 0.75

[The olfactory function in the patients with the curved nasal septum before and after surgical treatment]. Vestn Otorinolaringol (2011) 0.75